Skip to main content
SpringerLink
Log in

Metabolic syndrome: joint diagnostic criteria and links with comorbidities

  • Letter to the Editor
  • Published:
Hormones Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP (2018) Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens) 17(3):299–313

  2. Alberti KG, Eckel RH, Grundy SM et al (2009) International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1652

    Article  CAS  Google Scholar 

  3. Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P (2018) Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 42(Suppl 1):S10–S15

    Google Scholar 

  4. Athyros VG, Ganotakis ES, Tziomalos K et al (2010) Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 26:713–719

    Article  PubMed  Google Scholar 

  5. Katsiki N, Athyros VG, Mikhailidis DP (2015) Metabolic syndrome: different definitions and gender-specific associations with cardiovascular risk factors. Diab Vasc Dis Res 12:471–472

    Article  CAS  PubMed  Google Scholar 

  6. Athyros VG, Ganotakis E, Kolovou GD, et al (2011) Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT) collaborative. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol 9: 647–657

  7. Grundy SM, Cleeman JI, Daniels SR et al (2005) American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752

    Article  Google Scholar 

  8. Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A (2018) Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome? Curr Vasc Pharmacol 16:219–227

    Article  CAS  PubMed  Google Scholar 

  9. Athyros VG, Tziomalos K, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP (2015) Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update. World J Gastroenterol 21:6820–6834

    Article  PubMed  PubMed Central  Google Scholar 

  10. Athyros VG, Alexandrides TK, Bilianou H et al (2017) The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An expert panel statement. Metabolism 71:17–32

    Article  CAS  PubMed  Google Scholar 

  11. Katsiki N, Mikhailidis DP (2018) Abnormal peri-organ or intra-organ fat deposition and vascular risk. Angiology 2018;69(10):841–842

  12. Katsiki N, Athyros VG, Mikhailidis DP (2016) Abnormal peri-organ or intra-organ fat (APIFat) deposition: an underestimated predictor of vascular risk? Curr Vasc Pharmacol 14:432–441

    Article  CAS  PubMed  Google Scholar 

  13. Katsiki N, Mikhailidis DP, Wierzbicki AS (2013) Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol 28:458–463

    Article  PubMed  Google Scholar 

  14. Fitzgibbons TP, Czech MP (2014) Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc 3:e000582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Katsiki N, Mikhailidis DP, Mantzoros C (2018) Non-alcoholic fatty liver disease and colorectal cancer: a marker of risk or common causation? Metabolism 2018;87:A10–A13

  16. Esposito K, Capuano A, Giugliano D (2014) Metabolic syndrome and cancer: holistic or reductionist? Endocrine 45:362–364

    Article  CAS  PubMed  Google Scholar 

  17. Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE (2017) Nonalcoholic fatty liver disease: evolving paradigms. World J Gastroenterol 23:6571–6592

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Propedeutic Clinic of Internal Medicine, Aristotle University of Thessaloniki, 12 Dionyssiou Str Ano Poli, 546 34, Thessaloniki, Greece

    Niki Katsiki, Michael Doumas & Vasilios Athyros

Authors
  1. Niki Katsiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Doumas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vasilios Athyros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niki Katsiki.

Ethics declarations

Conflict of interest

NK has given talks, attended conferences, and participated in trials sponsored by Amgen, Angelini, Astra Zeneca, Boehringer Ingelheim, Galenica, MSD, Novartis, Novo Nordisk, Sanofi, and WinMedica. MD has nothing to declare. VA has given talks, attended conferences, and participated in trials sponsored by MSD, Angelini, Sanofi, and Amgen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katsiki, N., Doumas, M. & Athyros, V. Metabolic syndrome: joint diagnostic criteria and links with comorbidities. Hormones 18, 107–108 (2019). https://doi.org/10.1007/s42000-018-0074-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42000-018-0074-9

Search

Navigation